- Home
- PRFX vs NBY Comparison
PRFX vs NBY Comparison
Compare PRFX & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRFX
- NBY
- Stock Information
- Founded
- PRFX 2007
- NBY 2000
- Country
- PRFX Israel
- NBY United States
- Employees
- PRFX N/A
- NBY N/A
- Industry
- PRFX Biotechnology: Pharmaceutical Preparations
- NBY
- Sector
- PRFX Health Care
- NBY
- Exchange
- PRFX Nasdaq
- NBY Nasdaq
- Market Cap
- PRFX 3.8M
- NBY 3.4M
- IPO Year
- PRFX 2020
- NBY 2007
- Fundamental
- Price
- PRFX $1.88
- NBY $0.53
- Analyst Decision
- PRFX Hold
- NBY Strong Buy
- Analyst Count
- PRFX 1
- NBY 1
- Target Price
- PRFX N/A
- NBY $0.85
- AVG Volume (30 Days)
- PRFX 3.8M
- NBY 48.3K
- Earning Date
- PRFX 05-14-2025
- NBY 05-20-2025
- Dividend Yield
- PRFX N/A
- NBY N/A
- EPS Growth
- PRFX N/A
- NBY N/A
- EPS
- PRFX N/A
- NBY N/A
- Revenue
- PRFX N/A
- NBY $9,781,000.00
- Revenue This Year
- PRFX N/A
- NBY $23.91
- Revenue Next Year
- PRFX N/A
- NBY $32.05
- P/E Ratio
- PRFX N/A
- NBY N/A
- Revenue Growth
- PRFX N/A
- NBY N/A
- 52 Week Low
- PRFX $0.43
- NBY $0.36
- 52 Week High
- PRFX $16.63
- NBY $9.10
- Technical
- Relative Strength Index (RSI)
- PRFX 34.67
- NBY 46.62
- Support Level
- PRFX $2.22
- NBY $0.52
- Resistance Level
- PRFX $2.41
- NBY $0.64
- Average True Range (ATR)
- PRFX 0.14
- NBY 0.03
- MACD
- PRFX -0.02
- NBY 0.00
- Stochastic Oscillator
- PRFX 6.80
- NBY 41.83
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.